Lansforsakringar Fondforvaltning’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$62.9M	Buy	141,290 +4,979	+4%	+$2.22M	0.36%	54
2025 Q1	$66.1M	Sell	136,311 -8,397	-6%	-$4.07M	0.41%	47
2024 Q4	$58.3M	Buy	+144,708	New	+$58.3M	0.33%	59